Aras’s Significant Growth Investment by GI Partners
April 19, 2021
On April 19, 2021, Aras, the only resilient platform provider for digital industrial applications with open, low code technology, announced a substantial growth investment from GI Partners, a leading private investment firm. Cravath is representing Aras in connection with the transaction.
The Cravath team is led by partner George F. Schoen and includes partner Matthew M. Kelly on financing matters; partner Matthew J. Bobby and associate David Crampton on executive compensation and benefits matters; partner Lauren Angelilli and associates Arvind Ravichandran and Leon B. Dalezman on tax matters; and associate Carys J. Webb on intellectual property matters. Peter Kim and Michael Svedman also worked on corporate matters and Temiloluwa A. Dele‑Dare worked on financing matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 2013, New York University School of LawJohn Norton Pomeroy Scholar; Benjamin Butler Scholar; Order of the Coif, magna cum laude
-
A.B., 2006, Dartmouth Collegecum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2012, Harvard Law Schoolmagna cum laude
-
M.A., 2009, University of Pennsylvania
-
B.A., 2009, University of PennsylvaniaPhi Beta Kappa, summa cum laude
- New York
Education
Admitted In
-
J.D., 2000, Harvard Law Schoolcum laude
-
B.S., 1996, The Wharton School of the University of Pennsylvaniamagna cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2012, Columbia Law School
-
B.A., 2009, Columbia College
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
April 16, 2021
IBM’s Acquisition of myInvenio
On April 15, 2021, IBM announced a definitive agreement to acquire myInvenio, a process mining software company based in Reggio Emilia, Italy. The acquisition will provide organizations with data‑driven software to help them identify the most impactful business processes to automate using AI – including sales, procurement, production and accounting. Financial details were not disclosed. Cravath is representing IBM in connection with the transaction.
Deals & Cases
April 15, 2021
Thermo Fisher Scientific’s $20.9 Billion Acquisition of PPD, Inc.
On April 15, 2021, Thermo Fisher Scientific Inc. (“Thermo Fisher”), a leader in serving science, and PPD, Inc. (“PPD”), a leading provider of clinical research services to the pharma and biotech industry, announced that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share for a total cash purchase price of $17.4 billion plus the assumption of approximately $3.5 billion of net debt. Cravath is representing Thermo Fisher in connection with the transaction.
Deals & Cases
April 12, 2021
DiaSorin’s $1.8 Billion Acquisition of Luminex Corporation
On April 11, 2021, DiaSorin S.p.A. (“DiaSorin”), a leading global diagnostics company, announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (“Luminex”), a leader in multiplexing technology, for a price of $37.00 per share in an all‑cash transaction corresponding to an enterprise value of approximately $1.8 billion. Cravath is representing DiaSorin in connection with the transaction.
Deals & Cases
April 08, 2021
CommScope’s Spin‑Off of its Home Networks Business into Independent Public Company
On April 8, 2021, CommScope Holding Company, Inc., a global leader in connectivity solutions for communications networks, announced its plan to spin off its Home Networks business and other initiatives. The separation is intended to be executed through a tax‑free spin‑off to CommScope shareholders to form a new and independent publicly traded company. Cravath is representing CommScope in connection with the transaction.
